Study to evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants with Mild Acne

Trial Identifier: VBE00009
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: July 2025
Primary Completion Date: June 2029
Study Completion Date: June 2029
Condition: Skin Conditions

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
UNITED STATES, California ENCINO, California, UNITED STATES, 91436
UNITED STATES, Florida BRANDON, Florida, UNITED STATES, 33511
UNITED STATES, Florida JACKSONVILLE, Florida, UNITED STATES, 32216
UNITED STATES, Louisiana New Orleans, Louisiana, UNITED STATES, 70115